In line with these results, analysis of the cancer database shows that E2F4, and, albeit at a lower extent, the E2F5 homologue, as well as DP1 and p130 are expressed in both normal and cancer tissues from different anatomical sites (Fig. S3). Here, E2F4 is linked to cancer.